Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | 21 Oct 2021 | |
Neoplasms | Preclinical | DE | HepaRegeniX GmbHStartup | 21 Oct 2021 |